DOI QR코드

DOI QR Code

Successful in vitro fertilization pregnancy and delivery after a fertility-sparing laparoscopic operation in a patient with a papillary thyroid carcinoma arising from a mature cystic teratoma

  • Hong, Kirim (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Han, Anthony Kyung Woo (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Kim, Mi-La (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Yun, Bo Seong (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Jun, Hye Sun (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Seong, Seok Ju (Department of Obstetrics and Gynecology, CHA Gangnam Medical Center, CHA University) ;
  • Shim, Jeong Yun (Department of Pathology, CHA Gangnam Medical Center, CHA University)
  • Received : 2019.06.07
  • Accepted : 2019.07.12
  • Published : 2019.09.30

Abstract

Malignant transformation of ovarian mature cystic teratomas is rare, and papillary thyroid cancer occurs in 0.1%-0.3% of ovarian teratomas that undergo malignant transformation. We describe a case of successful in vitro fertilization pregnancy and delivery after a fertility-sparing laparoscopic operation in a patient with papillary thyroid carcinoma arising from a mature cystic teratoma.

Keywords

References

  1. Peterson WF, Prevost EC, Edmunds FT, Hundley JM Jr, Morris FK. Epidermoid carcinoma arising in a benign cystic teratoma: a report of 15 cases. Am J Obstet Gynecol 1956;71:173-89. https://doi.org/10.1016/0002-9378(56)90693-7
  2. Hirakawa T, Tsuneyoshi M, Enjoji M. Squamous cell carcinoma arising in mature cystic teratoma of the ovary: clinicopathologic and topographic analysis. Am J Surg Pathol 1989;13:397-405. https://doi.org/10.1097/00000478-198905000-00007
  3. Scully RE, Young RH, Clement RB. Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament: atlas of tumor pathology. Washington: Armed Forces Institute of Pathology; 1998.
  4. McGill JF, Sturgeon C, Angelos P. Metastatic struma ovarii treated with total thyroidectomy and radioiodine ablation. Endocr Pract 2009;15:167-73. https://doi.org/10.4158/EP.15.2.167
  5. Talerman A. Germ cell tumors of the ovary. In: Kurman RJ, editor. Blaustein's pathology of the female genital tract. 4th ed. New York: Springer-Verlag; 1994. p. 849-914.
  6. Rim SY, Kim SM, Choi HS. Malignant transformation of ovarian mature cystic teratoma. Int J Gynecol Cancer 2006;16:140-4. https://doi.org/10.1111/j.1525-1438.2006.00285.x
  7. Wolff EF, Hughes M, Merino MJ, Reynolds JC, Davis JL, Cochran CS, et al. Expression of benign and malignant thyroid tissue in ovarian teratomas and the importance of multimodal management as illustrated by a BRAF-positive follicular variant of papillary thyroid cancer. Thyroid 2010;20:981-7. https://doi.org/10.1089/thy.2009.0458
  8. van Wijk JP, Broekhuizen-de Gast HS, Smits AJ, Schipper ME, Zelissen PM. Scintigraphic detection of benign ovarian teratoma after total thyroidectomy and radioactive iodine for differentiated thyroid cancer. J Clin Endocrinol Metab 2012;97:1094-5. https://doi.org/10.1210/jc.2011-2433
  9. Lakshmanan M, Reynolds JC, Del Vecchio S, Merino MJ, Norton JA, Robbins J. Pelvic radioiodine uptake in a rectal wall teratoma after thyroidectomy for papillary carcinoma. J Nucl Med 1992;33:1848-50.
  10. Dane C, Ekmez M, Karaca A, Ak A, Dane B. Follicular variant of papillary thyroid carcinoma arising from a dermoid cyst: a rare malignancy in young women and review of the literature. Taiwan J Obstet Gynecol 2012;51:421-5. https://doi.org/10.1016/j.tjog.2012.07.019
  11. Kraemer B, Grischke EM, Staebler A, Hirides P, Rothmund R. Laparoscopic excision of malignant struma ovarii and 1 year followup without further treatment. Fertil Steril 2011;95:2124.e9-12. https://doi.org/10.1016/j.fertnstert.2010.12.047
  12. Kim JY, Lim YJ, Lee JS, Lee SJ, Park JY, Nam JH. Papillary type thyroid carcinoma originating in struma ovarii: case report and review of the literature. Korean J Obstet Gynecol 2011;54:548-52. https://doi.org/10.5468/KJOG.2011.54.9.548
  13. Dardik RB, Dardik M, Westra W, Montz FJ. Malignant struma ovarii: two case reports and a review of the literature. Gynecol Oncol 1999;73:447-51. https://doi.org/10.1006/gyno.1999.5355
  14. Devaney K, Snyder R, Norris HJ, Tavassoli FA. Proliferative and histologically malignant struma ovarii: a clinicopathologic study of 54 cases. Int J Gynecol Pathol 1993;12:333-43. https://doi.org/10.1097/00004347-199310000-00008
  15. Uzum AK, Iyibozkurt C, Canbaz B, Ciftci SD, Aksakal N, Kapran Y, et al. Management and follow-up results of an incidental thyroid carcinoma in a young woman with ovarian teratoma. Gynecol Endocrinol 2013;29:724-6. https://doi.org/10.3109/09513590.2013.798277
  16. Iwahashi N, Deguchi Y, Horiuchi Y, Noguchi T, Yahata T, Ota N, et al. Live birth following laparoscopic fertility-sparing surgery for papillary thyroid carcinoma arising from mature ovarian cystic teratoma: a case report. Mol Clin Oncol 2018;9:613-6.
  17. Fathalla MF. Incessant ovulation: a factor in ovarian neoplasia? Lancet 1971;2:163. https://doi.org/10.1016/S0140-6736(71)92335-X
  18. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983;71:717-21.
  19. Rizzuto I, Behrens RF, Smith LA. Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility. Cochrane Database Syst Rev 2013;(8):CD008215.

Cited by

  1. Malignant struma ovarii: From case to analysis vol.47, pp.9, 2019, https://doi.org/10.1111/jog.14902